•
GTV not properly defined and therefore inadequate
dose coverage
•
Treatment planning itself was inappropriate and
therefore inadequate dose to targets
•
Inappropriate prescribed dose
•
Protracted overall treatment time
Sources of non-compliance
Peters, et al. J Clin Oncol 2010; 28: 2996-3001